Flower City Capital

Position in KURA — Kura Oncology, Inc.

CIK 1808394 PITTSFORD, NY

Position in KURA

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$197,460

+$51,120 QoQ

Shares Held

18,000

0.0% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

1.40%

of 13F equity value

Holder Rank

#144

of 220 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Flower City Capital holds $929,624 across 5 Biotechnology names. KURA ranks #3 (21.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	500	$311,770
2	IMRX	Immuneering Corp	55,029	$274,594
3	KURA	Kura Oncology, Inc. This page	18,000	$197,460
4	PGEN	Precigen, Inc.	20,000	$114,000
5	OTLK	Outlook Therapeutics, Inc.	20,000	$31,800

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$197,460	18,000	0.0%	Shares	Sole	2026-07-07
2026-03-31	$146,340	18,000	+50.0%	Shares	Sole	2026-04-14
2025-12-31	$124,680	12,000	+20.0%	Shares	Sole	2026-01-22
2025-09-30	$88,500	10,000	0.0%	Shares	Sole	2025-10-08
2025-06-30	$57,700	10,000	-16.7%	Shares	Sole	2025-07-16
2025-03-31	$79,200	12,000	—	Shares	Sole	2025-04-22
No filing history on record for this holder in this stock.